scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.NEUROBIOLAGING.2008.07.021 |
P8608 | Fatcat ID | release_tvtnyk355vetpg6t7m4qowyzwy |
P932 | PMC publication ID | 2909664 |
P698 | PubMed publication ID | 18771816 |
P5875 | ResearchGate publication ID | 23237940 |
P50 | author | Gunnar K. Gouras | Q37374939 |
Estibaliz Capetillo-Zarate | Q79758990 | ||
P2093 | author name string | Teresa A Milner | |
Michael T Lin | |||
Reisuke H Takahashi | |||
P2860 | cites work | Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice | Q22242267 |
Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain | Q28137790 | ||
Kinesin-mediated axonal transport of a membrane compartment containing beta-secretase and presenilin-1 requires APP | Q28592685 | ||
beta-Amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity | Q28593175 | ||
Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction | Q29547778 | ||
Intracellular amyloid-beta in Alzheimer's disease | Q29615626 | ||
Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model | Q29617937 | ||
Alzheimer disease models and human neuropathology: similarities and differences | Q30499574 | ||
Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's disease | Q32028060 | ||
Intracellular Abeta and cognitive deficits precede beta-amyloid deposition in transgenic arcAbeta mice | Q33252237 | ||
Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes | Q34452028 | ||
Intracellular mechanisms of amyloid accumulation and pathogenesis in Alzheimer's disease | Q34509753 | ||
Synaptic slaughter in Alzheimer's disease | Q35595427 | ||
Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology | Q35747757 | ||
Intraneuronal Abeta42 accumulation in human brain. | Q35793325 | ||
Intraneuronal Abeta accumulation and origin of plaques in Alzheimer's disease | Q36196976 | ||
Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology | Q36724967 | ||
Review on the APP/PS1KI mouse model: intraneuronal Abeta accumulation triggers axonopathy, neuron loss and working memory impairment | Q37053943 | ||
Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. | Q39173722 | ||
Hippocampal alpha2a-adrenergic receptors are located predominantly presynaptically but are also found postsynaptically and in selective astrocytes | Q39758463 | ||
Tau protein is phosphorylated by cyclic AMP-dependent protein kinase and calcium/calmodulin-dependent protein kinase II within its microtubule-binding domains at Ser-262 and Ser-356. | Q42059767 | ||
Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease | Q42474769 | ||
Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils | Q43718666 | ||
Altered metabolism of the amyloid beta precursor protein is associated with mitochondrial dysfunction in Down's syndrome | Q43906174 | ||
Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice | Q44182586 | ||
Early intraneuronal Abeta deposition in the hippocampus of APP transgenic mice | Q44289387 | ||
Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome | Q45007178 | ||
Intracellular Abeta42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease | Q45153471 | ||
Oligomerization of Alzheimer's beta-amyloid within processes and synapses of cultured neurons and brain. | Q47798328 | ||
Lipopolysaccharide-induced-neuroinflammation increases intracellular accumulation of amyloid precursor protein and amyloid beta peptide in APPswe transgenic mice | Q48196554 | ||
Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice | Q48242315 | ||
Intraneuronal amyloid beta and reduced brain volume in a novel APP T714I mouse model for Alzheimer's disease. | Q48366612 | ||
Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. | Q48404445 | ||
Apolipoprotein E and low density lipoprotein receptor-related protein facilitate intraneuronal Abeta42 accumulation in amyloid model mice | Q48408205 | ||
AbetaPP induces cdk5-dependent tau hyperphosphorylation in transgenic mice Tg2576. | Q48439872 | ||
Intraneuronal Abeta42 accumulation in Down syndrome brain | Q48443635 | ||
A conformation- and phosphorylation-dependent antibody recognizing the paired helical filaments of Alzheimer's disease. | Q48540026 | ||
Beta-amyloid accumulation impairs multivesicular body sorting by inhibiting the ubiquitin-proteasome system. | Q48577748 | ||
The Arctic Alzheimer mutation facilitates early intraneuronal Abeta aggregation and senile plaque formation in transgenic mice | Q48690756 | ||
Intraneuronal Abeta accumulation precedes plaque formation in beta-amyloid precursor protein and presenilin-1 double-transgenic mice | Q48846848 | ||
Intraneuronal abeta-amyloid precedes development of amyloid plaques in Down syndrome | Q48945429 | ||
Altered mitogen-activated protein kinase signaling, tau hyperphosphorylation and mild spatial learning dysfunction in transgenic rats expressing the beta-amyloid peptide intracellularly in hippocampal and cortical neurons. | Q51996386 | ||
Abeta localization in abnormal endosomes: association with earliest Abeta elevations in AD and Down syndrome. | Q53264641 | ||
p25/cyclin-dependent kinase 5 induces production and intraneuronal accumulation of amyloid beta in vivo. | Q53594164 | ||
Inter-laboratory comparison of neuropathological assessments of β-amyloid protein: a study of the BrainNet Europe consortium | Q59690267 | ||
P433 | issue | 7 | |
P921 | main subject | Alzheimer's disease | Q11081 |
P304 | page(s) | 1145-1152 | |
P577 | publication date | 2008-09-03 | |
P1433 | published in | Neurobiology of Aging | Q7002141 |
P1476 | title | Co-occurrence of Alzheimer's disease ß-amyloid and τ pathologies at synapses | |
P478 | volume | 31 |
Q35353667 | AD synapses contain abundant Aβ monomer and multiple soluble oligomers, including a 56-kDa assembly |
Q50420723 | AD-Related N-Terminal Truncated Tau Is Sufficient to Recapitulate In Vivo the Early Perturbations of Human Neuropathology: Implications for Immunotherapy |
Q37618817 | Abnormal interaction of oligomeric amyloid-β with phosphorylated tau: implications to synaptic dysfunction and neuronal damage |
Q35223831 | Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer's disease |
Q34570846 | Accumulation of intraneuronal β-amyloid 42 peptides is associated with early changes in microtubule-associated protein 2 in neurites and synapses |
Q92510463 | Aging, Metabolism, Synaptic Activity, and Aβ in Alzheimer's Disease |
Q38532705 | Alzheimer's Disease, Drosophila melanogaster and Polyphenols. |
Q35899503 | Alzheimer's disease: a clinical practice-oriented review |
Q28087158 | Analyzing dendritic spine pathology in Alzheimer's disease: problems and opportunities |
Q48884122 | Beta-amyloid induced changes in A-type K⁺ current can alter hippocampo-septal network dynamics. |
Q36817618 | Blocking the interaction between apolipoprotein E and Aβ reduces intraneuronal accumulation of Aβ and inhibits synaptic degeneration |
Q38350075 | Cellular factors modulating the mechanism of tau protein aggregation |
Q33948010 | Computational study of hippocampal-septal theta rhythm changes due to β-amyloid-altered ionic channels |
Q36342011 | Critical role of intraneuronal Aβ in Alzheimer's disease: technical challenges in studying intracellular Aβ. |
Q98196923 | Defining and predicting transdiagnostic categories of neurodegenerative disease |
Q36691716 | Development of new fusion proteins for visualizing amyloid-β oligomers in vivo |
Q55314136 | Divergent topological networks in Alzheimer's disease: a diffusion kurtosis imaging analysis. |
Q30497246 | Effects of synaptic modulation on beta-amyloid, synaptophysin, and memory performance in Alzheimer's disease transgenic mice. |
Q36137237 | Extensive p-tau pathology and SDS-stable p-tau oligomers in Alzheimer's cortical synapses |
Q38227862 | Glia and zinc in ageing and Alzheimer's disease: a mechanism for cognitive decline? |
Q35598903 | Graph theoretic analysis of structural connectivity across the spectrum of Alzheimer's disease: The importance of graph creation methods |
Q42219931 | Heterogeneous Association of Alzheimer's Disease-Linked Amyloid-β and Amyloid-β Protein Precursor with Synapses |
Q55377473 | How to Build a Functional Connectomic Biomarker for Mild Cognitive Impairment From Source Reconstructed MEG Resting-State Activity: The Combination of ROI Representation and Connectivity Estimator Matters. |
Q41849339 | Impaired plasticity of cortical dendritic spines in P301S tau transgenic mice |
Q34043165 | Inducing autophagy by rapamycin before, but not after, the formation of plaques and tangles ameliorates cognitive deficits |
Q37969262 | Interaction between pathogenic proteins in neurodegenerative disorders |
Q53324250 | Interaction between α-synuclein and other proteins in neurodegenerative disorders. |
Q39236779 | Interactions of pathological proteins in neurodegenerative diseases |
Q42465835 | Intracellular accumulation of amyloid-β (Aβ) protein plays a major role in Aβ-induced alterations of glutamatergic synaptic transmission and plasticity. |
Q27307787 | Intraneuronal Aβ accumulation induces hippocampal neuron hyperexcitability through A-type K(+) current inhibition mediated by activation of caspases and GSK-3. |
Q35646336 | Involvement of Intracellular and Mitochondrial Aβ in the Ameliorative Effects of Huperzine A against Oligomeric Aβ42-Induced Injury in Primary Rat Neurons |
Q35860859 | Isolation of synaptic terminals from Alzheimer's disease cortex |
Q93013693 | Kv1.3 Channel as a Key Therapeutic Target for Neuroinflammatory Diseases: State of the Art and Beyond |
Q33600113 | MEG Beamformer-Based Reconstructions of Functional Networks in Mild Cognitive Impairment |
Q47280369 | Memantine for the Treatment of Dementia: A Review on its Current and Future Applications. |
Q38195641 | Microglia receptors and their implications in the response to amyloid β for Alzheimer's disease pathogenesis |
Q51029900 | Neurofibrillary Tangles of Aβx-40 in Alzheimer's Disease Brains. |
Q38297925 | Neuropathology and biochemistry of Aβ and its aggregates in Alzheimer's disease. |
Q32178128 | Neuroprotection by IFN-γ via astrocyte-secreted IL-6 in acute neuroinflammation |
Q34544243 | Oligomeric Aβ-induced synaptic dysfunction in Alzheimer's disease |
Q38832929 | Overexpression of Heme Oxygenase 1 Impairs Cognitive Ability and Changes the Plasticity of the Synapse |
Q36873070 | Oxidative stress and hippocampal synaptic protein levels in elderly cognitively intact individuals with Alzheimer's disease pathology |
Q99585475 | Passive immunotherapy for N-truncated tau ameliorates the cognitive deficits in two mouse Alzheimer's disease models |
Q39163007 | Plaque formation and the intraneuronal accumulation of β-amyloid in Alzheimer's disease |
Q41564705 | Pseudo-acetylation of multiple sites on human Tau proteins alters Tau phosphorylation and microtubule binding, and ameliorates amyloid beta toxicity |
Q38876654 | Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials. |
Q26799870 | Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease |
Q58780923 | Roles of Microglial and Monocyte Chemokines and Their Receptors in Regulating Alzheimer's Disease-Associated Amyloid-β and Tau Pathologies |
Q40277605 | Selective impairment of hippocampus and posterior hub areas in Alzheimer's disease: an MEG-based multiplex network study |
Q34639435 | Single-subject grey matter graphs in Alzheimer's disease |
Q34028039 | Synapses, synaptic activity and intraneuronal abeta in Alzheimer's disease |
Q36468755 | Synaptic Amyloid-β Oligomers Precede p-Tau and Differentiate High Pathology Control Cases |
Q50440796 | Synaptic Dysfunction in Alzheimer's Disease: Aβ, Tau, and Epigenetic Alterations. |
Q30491040 | Synaptic activity reduces intraneuronal Abeta, promotes APP transport to synapses, and protects against Abeta-related synaptic alterations |
Q35035669 | Synaptic change in the posterior cingulate gyrus in the progression of Alzheimer's disease |
Q28577234 | Synaptic protein α1-takusan mitigates amyloid-β-induced synaptic loss via interaction with tau and postsynaptic density-95 at postsynaptic sites |
Q37684106 | Tau protein modifications and interactions: their role in function and dysfunction |
Q51026158 | The γ-secretase modulator CHF5074 reduces the accumulation of native hyperphosphorylated tau in a transgenic mouse model of Alzheimer's disease. |
Q34765883 | αν and β1 Integrins mediate Aβ-induced neurotoxicity in hippocampal neurons via the FAK signaling pathway |